Veenat 100mg is a targeted therapy medication used to treat various types of blood and gastrointestinal cancers. It contains Imatinib Mesylate, which works by stopping the growth of cancer cells.
Veenat 100mg is a formulation of Imatinib, a tyrosine kinase inhibitor used in the treatment of specific cancers such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It is a reliable option for long-term management of these cancers, particularly when initiated early in the disease course.
Imatinib is a tyrosine kinase inhibitor that blocks the activity of abnormal proteins (like BCR-ABL) that signal cancer cells to multiply. By inhibiting these proteins, it prevents cancer cell growth and triggers programmed cell death.
Side Effects:
Common Side Effects:
Nausea
Vomiting
Diarrhea
Fatigue
Rash
Edema (swelling, especially around the eyes or limbs)
Severe Side Effects:
Myelosuppression (low blood cell counts)
Liver toxicity
Severe fluid retention or pleural effusion
Bleeding
Severe allergic reactions (anaphylaxis, angioedema)
Dosage (Typical Recommended Dose):
100mg to 800mg daily depending on the type and stage of cancer
For CML (chronic phase), usually 400mg daily
For pediatric patients or certain adults, Veenat 100mg may be taken multiple times daily as prescribed
Method of Administration:
Take orally with a full glass of water
Preferably with food to minimize gastrointestinal upset
Swallow whole, do not crush or chew
Precautions:
Regular blood tests are required to monitor blood counts and liver function
Use effective contraception during treatment
Caution in patients with liver, kidney, or heart disease
Avoid alcohol and grapefruit juice
Not recommended during pregnancy or breastfeeding unless clearly needed
Drug Interactions:
CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) may increase toxicity
CYP3A4 inducers (e.g., rifampin, phenytoin) may reduce efficacy
Warfarin, acetaminophen, and NSAIDs may need dose adjustments or close monitoring
Allergies:
Contraindicated in patients with known hypersensitivity to Imatinib
Watch for symptoms such as rashes, itching, difficulty breathing, and swelling
Overdose Information:
Symptoms may include nausea, vomiting, dizziness, and severe swelling
Seek immediate medical attention or contact a poison control center
Missed Dose Instructions:
Take the missed dose as soon as you remember
If it's close to your next dose, skip the missed dose
Do not double up on doses
Additional Notes:
Maintain hydration and balanced nutrition
Inform healthcare providers before surgery or starting new medication
Long-term use may require dose adjustments based on response and tolerability
Product Intro:
Veenat 100mg is a formulation of Imatinib, a tyrosine kinase inhibitor used in the treatment of specific cancers such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It is a reliable option for long-term management of these cancers, particularly when initiated early in the disease course.
Imatinib is a tyrosine kinase inhibitor that blocks the activity of abnormal proteins (like BCR-ABL) that signal cancer cells to multiply. By inhibiting these proteins, it prevents cancer cell growth and triggers programmed cell death.
Side Effects:
Common Side Effects:
Nausea
Vomiting
Diarrhea
Fatigue
Rash
Edema (swelling, especially around the eyes or limbs)
Severe Side Effects:
Myelosuppression (low blood cell counts)
Liver toxicity
Severe fluid retention or pleural effusion
Bleeding
Severe allergic reactions (anaphylaxis, angioedema)
Dosage (Typical Recommended Dose):
100mg to 800mg daily depending on the type and stage of cancer
For CML (chronic phase), usually 400mg daily
For pediatric patients or certain adults, Veenat 100mg may be taken multiple times daily as prescribed
Method of Administration:
Take orally with a full glass of water
Preferably with food to minimize gastrointestinal upset
Swallow whole, do not crush or chew
Precautions:
Regular blood tests are required to monitor blood counts and liver function
Use effective contraception during treatment
Caution in patients with liver, kidney, or heart disease
Avoid alcohol and grapefruit juice
Not recommended during pregnancy or breastfeeding unless clearly needed
Drug Interactions:
CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) may increase toxicity
CYP3A4 inducers (e.g., rifampin, phenytoin) may reduce efficacy
Warfarin, acetaminophen, and NSAIDs may need dose adjustments or close monitoring
Allergies:
Contraindicated in patients with known hypersensitivity to Imatinib
Watch for symptoms such as rashes, itching, difficulty breathing, and swelling
Overdose Information:
Symptoms may include nausea, vomiting, dizziness, and severe swelling
Seek immediate medical attention or contact a poison control center
Missed Dose Instructions:
Take the missed dose as soon as you remember
If it's close to your next dose, skip the missed dose
Do not double up on doses
Additional Notes:
Maintain hydration and balanced nutrition
Inform healthcare providers before surgery or starting new medication
Long-term use may require dose adjustments based on response and tolerability
